It appears that your browser may be outdated and performance may be limited. The My Study builder is best viewed with the latest internet browsers. However, if you’d prefer to use our standard form, you can access it below.

Go to Internet Explorer Quick Quote Form

Dismiss this message

Salivary IgM ELISA Kit

Technical Summary

Assay Protocol
Rev. 05.01.20
Specifications
Catalog#: 1-4002
Regulatory Status: RUO
Format: 96-well plate
Assay Time: ~ 3 hrs
Sample Volume/Test: 10 µL
Sensitivity: 0.03 ng/mL
Assay Range: 0.39 – 25 ng/mL
Storage Requirements: 2-8°C
Tests Per Kit
Singlet: 76
Duplicate: 38
Target Analyte
Technical Documentation

Salivary IgM Assay Kit Overview

Intended Use

The Salimetrics® Salivary Human Total IgM ELISA Kit is an enzyme-linked immunoassay specifically designed and validated for the quantitative measurement of human total IgM in oral fluid. It is not intended for diagnostic use. This assay kit was optimized for human salivary research and has not been validated for other human sample types, such as serum or plasma or samples from other species. For further information about this kit, its application, or the procedures in this insert, please contact the technical service team at Salimetrics or your local sales representative.

Introduction

Immunoglobulin M, or IgM, is one of five classes of antibodies found in humans, and is present as part of both the natural and adaptive immune response. Natural IgMs are low affinity pentameric molecules that bind to invading pathogens without requiring prior exposure. They act to directly neutralize viruses, activate complement, trigger phagocytosis and drive antibody dependent cell cytotoxicity. Adaptive IgM is the first antibody produced in response to invading pathogens and functions in a similar way to natural IgM, but are higher affinity molecules and are an important part of the adaptive immune response (4). IgM is the first immunoglobulin molecule found in the fetus, developing in the second half of pregnancy. The majority of IgM is pentameric and includes a molecule referred to as the J chain, a key structural component also found in polymeric IgA. IgM also forms tetramers and hexamers, however in this case the J chain is absent. In contrast to IgG, IgM antibodies peak early in the course of humoral immune responses waning after several weeks and are thus useful in the determination of recent infections or pathogen exposure. One important use for measuring antigen specific IgM in saliva is during serological surveys when assessing outbreaks of infectious diseases, for instance with the recent COVID-19 outbreak. Similar to IgM, the major source of IgM in saliva is blood, and its entry is through gingival crevicular fluid (GCF). Due to this, the total amount of IgM can vary depending on the level of serum component representation. Therefore, when measuring pathogen specific IgM, total IgM can be used to qualify a saliva sample to assure sufficient levels of total IgM in the saliva sample and provide confidence in the pathogen specific IgM results. In this regard, total IgM may be essential to prove a negative pathogen specific test result. In addition, this assay may be used to qualify samples for testing after sample storage.

SALIVARY HUMAN TOTAL IgM ASSAY PRINCIPLE

This is an indirect sandwich ELISA kit. A “sandwich” is formed when the pre-coated capture Anti-Human IgM antibody present on the plate binds IgM in standards & samples, which is then bound by the Anti-Human IgM detection antibody linked to horseradish peroxidase. After each incubation, unbound components are washed away. Bound Anti-Human IgM Antibody Enzyme Conjugate is then added and the levels measured by the reaction of the horseradish peroxidase (HRP) enzyme to the substrate tetramethylbenzidine (TMB). This reaction produces a blue color. A yellow color is formed after stopping the reaction with an acidic solution. The optical density is read on a standard plate reader at 450 nm. The total amount of IgM Antibody Enzyme Conjugate detected is directly proportional to the amount of Total Human IgM present in the sample.

References & Salivary IgM Research

  1. Fereidan-Esfahani M, Nayfeh T, Warrington A, Howe CL, Rodriguez M. IgM Natural Autoantibodies in Physiology and the Treatment of Disease. Methods in molecular biology. 2019;1904:53-81.
  2. Michaud E, Mastrandrea C, Rochereau N, Paul S. Human Secretory IgM: An Elusive Player in Mucosal Immunity. Trends Immunol. 2020;41(2):141-56.
  3. Madar R, Straka S, Baska T. Detection of antibodies in saliva–an effective auxiliary method in surveillance of infectious diseases. Bratisl Lek Listy. 2002;103(1):38-41.
  4. Brandtzaeg P. Do salivary antibodies reliably reflect both mucosal and systemic immunity? Annals of the New York Academy of Sciences. 2007;1098:288-311.
Contact: Salimetrics (USA)
View All International Distributors

RESTART YOUR SAMPLE COLLECTION

Safe Saliva Collection in the COVID-19 Era
We have Good News!

Successfully recalibrate your saliva collection and handling procedures with these new safety and compliance guidelines for the COVID-19 era. These guidelines are good practice, easy to follow, and will allow you to begin or continue your research during this historical period of stress and unease… (Read More)

CALL 800.790.2258
ASK AN EXPERT   REQUEST A QUOTE

X
Restart Collection